The Top 25 Developers Of Cerebral Aneurysm Treatment Devices Worldwide
|発行||Research Facts Ltd.||商品コード||277836|
|出版日||ページ情報||英文 63 Pages
|世界の代表的な脳動脈瘤治療装置メーカー25社 The Top 25 Developers Of Cerebral Aneurysm Treatment Devices Worldwide|
|出版日: 2013年08月01日||ページ情報: 英文 63 Pages||
It is no surprise to learn then, that it is estimated that the cerebral aneurysm device market will be worth U.S.$ 1.0 billion in 2014.
There are various types of cerebral aneurysm e.g. saccular, fusiform and mycotic. Saccular aneurysms are the most common type and account for 80% to 90% of all intracranial aneurysms and are the most common cause of nontraumatic subarachnoid hemorrhage. Because of their shape, saccular aneurysms are also known as "berry" aneurysms. Fusiform aneurysms are a less common type of aneurysm. They are diffuse bulges of the vessel wall involving most of the entire circumference of the blood vessel itself. Mycotic aneurysms are rare and result from infection.
Cerebral aneurysms range in size, from quite small - about 1/8 inch - to nearly one inch. Aneurysms larger than one inch are called giant aneurysms, pose a particularly high risk, and are difficult to treat.
A number of factors can increase an individual's risk of developing a cerebral aneurysm e.g. hypertension, smoking, excessive alcohol consumption, drug use, congenital predisposition, traumatic head injury, complications from certain types of blood infections, diabetes, tumors and atherosclerosis.
Established treatment of a cerebral aneurysm involves exclusion from the circulation either by surgical clipping or by endovascular coiling. Recent technological advances have led to the development of new treatments e.g. Intracranial stents, liquid embolics and flow diversion devices.
This report profiles the Top 25 developers of cerebral aneurysm treatment devices worldwide. These are the companies with the experience, know-how and resources that enable them to develop, manufacture and market innovative products that compete effectively in global markets.
Profile information for each company in The Top 25 Developers Of Cerebral Aneurysm Treatment Devices Worldwide typically includes:
Usage: competitive/financial analysis and strategic partner/alliance identification.
This report is very useful to suppliers of e.g. materials like cobalt, nitinol, platinum, titanium etc. to identify top potential customers.
The Top 25 Developers Of Cerebral Aneurysm Treatment Devices Worldwide is ideal for distributors of neurovascular devices to identify the leading manufacturers with the best products.
The report is perfect for brain aneurysm foundations, neurointerventional surgery and neuroradiology societies, stroke associations etc..
Note: Most people will be aware of some of the major developers of cerebral aneurysm treatment devices such as MicroVention, Inc., Penumbra Inc. And Surpass Medical Ltd. But this report looks at all 25 of the top companies - companies like - Blockade Medical Inc. - founded in 2011, this Irvine, California headquartered Company's management team has over 65 years experience in the neurovascular field. Blockade Medical develops The Barricade Coil SystemTM, an embolization coil line which is designed to endovascularly occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels. On January 14, 2013, the Company announced that more than 100 patients had been successfully treated with the Barricade Coil SystemTM. Blockade Medical is organized to sell in over 25 countries and expects additional market commercialisation during 2013 as regulatory approvals are obtained.
Research Facts is a world leader in life sciences publishing. It was established in Dublin, Ireland in 2004. Its partners have over forty years combined experience in the business information industry. Research Facts' customers include most of the world's major diagnostics, pharmaceutical, biotechnology and medical device companies e.g. Abbott, Allergan, B. Braun, Bayer, Baxter, Biomet, Boehringer Ingelheim, Covance, Edwards Lifesciences, GE Healthcare, Genzyme, Intuitive Surgical, Ipsen, Medtronic, Millipore, Philips Medical, Qiagen, Siemens Healthcare, Smith & Nephew, Teva, Zentiva etc..
Research Facts has customers right across the globe e.g. Austria, Australia, Belgium, Brazil, Canada, Cyprus, Czech Republic, Denmark, France, Germany, Finland, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Kuwait, Luxembourg, Mauritius, Netherlands, Pakistan, Peru, Portugal, Russia, Saudi Arabia, Serbia, Singapore, Slovenia, South Africa, Spain, Sweden, Switzerland, United Kingdom, and the United States.
Research Facts' reports help you make informed decisions about the markets and organisations that affect your business.
Keywords: Aneurysm, Aneurysm Clip, Aneurysm Management, Aneurysm Neck-Bridge Device, Aneurysm Occlusion Device, Brain Aneurysm, Catheter-Based Device, Cerebral Aneurysm, Cerebral Vascular Disease, Cerebral Vascular Occlusion, Coil, Detachable Coil, Embolic Coil, Embolization Device, Endovascular Aneurysm Repair, Endovascular Coil System, Endovascular Embolic Coil, Flow Diversion, Intracranial Aneurysm, Liquid Embolics, Minimally Invasive Aneurysm Repair, Monomer, Neurosurgery, Neurovascular Aneurysm Therapy, Ruptured Cerebral Aneurysm, Stent, Surgical Clipping, Un-Ruptured Cerebral Aneurysm.